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The use of transcriptional factors as cell fate regulators are often the primary focus
in the direct reprogramming of somatic cells into neurons. However, in human
adult fibroblasts, deriving functionally mature neurons with high efficiency requires
additional neurogenic factors such as microRNAs (miRNAs) to evoke a neuronal
state permissive to transcription factors to exert their reprogramming activities. As
such, increasing evidence suggests brain-enriched miRNAs, miR-9/9∗ and miR-124,
as potent neurogenic molecules through simultaneously targeting of anti-neurogenic
effectors while allowing additional transcription factors to generate specific subtypes of
human neurons. In this review, we will focus on methods that utilize neuronal miRNAs
and provide mechanistic insights by which neuronal miRNAs, in synergism with brain-
region specific transcription factors, drive the conversion of human fibroblasts into
clinically relevant subtypes of neurons. Furthermore, we will provide insights into the
age signature of directly converted neurons and how the converted human neurons can
be utilized to model late-onset neurodegenerative disorders.
Keywords: microRNA, chromatin, neuronal conversion, reprogramming, neurogenesis, disease modeling, human
neurons
INTRODUCTION
Overcoming epigenetic barriers through direct cellular reprogramming has allowed scientists
to rapidly acquire cell types of interest for regenerative therapies and disease modeling. Direct
conversion of mouse fibroblasts into functional neurons have been demonstrated through the use
of transcription factors (Vierbuchen et al., 2010; Son et al., 2011; Chanda et al., 2014; Blanchard
et al., 2015). Empirically, however, obtaining mature human neurons from adult human fibroblasts
with transcription factors have been challenging (Caiazzo et al., 2011). To enhance reprogramming
efficiency and to promote neuronal maturation, small chemical molecules (Ladewig et al., 2012; Liu
et al., 2013; Pfisterer et al., 2016; Smith et al., 2016) and RNA molecules, miRNAs (Ambasudhan
et al., 2011; Yoo et al., 2011; Victor et al., 2014; Abernathy et al., 2017), have been used in
conjunction with transcription factors to robustly generate functional neurons from human
fibroblasts. The mechanism(s) by which miR-9/9∗ and miR-124 collectively drive robust neuronal
fate conversion remains an ongoing investigation, but through examining transcriptome and
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epigenetic changes at the genome-wide level, we attempt to
elucidate how miRNAs promote the neuronal identity during
direct conversion of human fibroblasts to neurons.
miRNAs AS POTENT CELL FATE
REGULATORS
Traditionally, transcription factors, in particular, pioneer
transcription factors, have been viewed as regulators and
determinants of cell fate. With domains that can interact directly
with chromatin and/or other modifier proteins, transcription
factors have been widely used for cellular reprogramming
(Iwafuchi-Doi and Zaret, 2014, 2016), including the generation
of induced pluripotent stem cells (iPSC) from somatic cells
(Takahashi and Yamanaka, 2006). Increasing studies across
different cellular contexts have revealed that miRNAs are also
potent cell fate regulators as miRNAs not only target large
repertoire of genes in genetic networks but also epigenetic
regulators necessary for the remodeling of the chromatin (Yoo
et al., 2009; Ivey and Srivastava, 2010; Gruber and Zavolan,
2013; Rajman and Schratt, 2017). Subsequently, miRNAs have
been used to generate iPSCs (Anokye-Danso et al., 2011),
cardiomyocytes (Jayawardena et al., 2012), and neurons (Yoo
et al., 2011) from fibroblasts.
miR-9/9∗ AND miR-124 ARE
NEUROGENIC MOLECULES
The acquisition of neuronal fate requires the downregulation
of the neuron-restrictive silencer factor (NRSF) or repressor
element-1 silencing transcription factor (REST) that represses
neuronal genes in non-neuronal cells, including the neuron-
specific miRNAs, miR-9/9∗, and miR-124 (miR-9/9∗-124) (Lagos-
Quintana et al., 2002; Lim et al., 2005; Conaco et al., 2006; Deo
et al., 2006). Both miR-9/9∗ and miR-124 are highly abundant in
neuronal tissues (Lagos-Quintana et al., 2002; Lim et al., 2005;
He et al., 2012), and are essential for neuronal differentiation
(Cheng et al., 2009; Dajas-Bailador et al., 2012; Xue Q. et al.,
2016) and the maintenance of neuronal identity through the
repression of anti-neural genes including cofactors of the REST
complex, RCOR1 and SCP1 (Visvanathan et al., 2007; Packer
et al., 2008). As overexpression of miR-9/9∗ (Leucht et al.,
2008; Zhao et al., 2009) and/or miR-124 (Krichevsky et al.,
2006; Cheng et al., 2009; Akerblom et al., 2012) in stem cells
or neural progenitors resulted in the precocious acquisition
of neuronal fate, demonstrating the function of miRNAs in
the activation of neuronal program (Lim et al., 2005). Ectopic
expression of miR-9/9∗-124 was also shown to drive the direct
conversion of primary human dermal fibroblasts into functional
neurons (Yoo et al., 2011). Therefore, knockdown of REST is
sufficient to promote neuronal identity in part due to miR-
9/9∗-124-dependent mechanisms (Drouin-Ouellet et al., 2017).
Furthermore, miR-9/9∗-124 orchestrates the reduction of REST
protein stability during neuronal reprogramming to promote
chromatin accessibility of neuronal loci (Lee et al., 2018) and
induction of neuronal genes (Abernathy et al., 2017; Drouin-
Ouellet et al., 2017; Lee et al., 2018). Interestingly, miR-124
alone has also been used in neuronal conversion with the
help of transcription factors (Ambasudhan et al., 2011; Jiang
et al., 2015). Here, we review current understanding of the
properties of miR-9/9∗ and miR-124 in both developmental and
cellular reprogramming contexts highlighting their synergistic
roles in coordinating the molecular switching of several critical
non-neuronal to neuronal components during mammalian
neurogenesis. We will mainly focus on the molecular switches
critical in epigenetic regulation such as chromatin remodeling
and DNA methylation, and transcriptome dynamics such as
alternative splicing underlying the adoption of the neuronal
identity. Our discussion will also include molecular pathways that
occur during in vivo neurogenesis and are also recapitulated in
the miRNA-directed reprogramming of human fibroblasts into
neurons for the successful overcoming of cell fate barriers.
miRNAs ORCHESTRATE THE
COMPOSITION OF BAF CHROMATIN
REMODELING COMPLEXES
Spatial and temporal reciprocity of homologous gene or isoform
expression during neurogenesis is a recurring theme. Previous
studies have indicated that the neurogenic and reprogramming
activity of miR-9/9∗ and miR-124 may be in part through the
direct targeting of subunits of the ATP-dependent BRG/BRM
associated factor (BAF) chromatin remodeling complexes (Yoo
et al., 2009; Staahl and Crabtree, 2013; Staahl et al., 2013).
Mammalian BAF complexes are large multi-subunit complexes
combinatorically assembled in a cell type-dependent manner.
The combinatorial assembly of different homologs and splice
variants of BAF subunit families confers functional specificity
as each subunit contains functional domains that recognized
DNA and/or modified histones (Wu et al., 2009; Zheng et al.,
2012). For example, embryonic stem cell (ESC) BAF (esBAF)
is characterized by BAF53a and a homodimer of BAF155,
as opposed to a heterodimer of BAF155 and BAF170 in
differentiated cells (Wang et al., 1996a,b; Ho et al., 2009b).
The esBAF complex is involved in maintaining pluripotency
by establishing an ESC-specific chromatin state permissive for
transcription factors and signaling molecules to access ESC-
associated genes (Ho et al., 2009a; Kidder et al., 2009). Although
BAF complexes are traditionally known to antagonize the
function of polycomb repressive complexes (PRC) to promote
chromatin accessibility for gene activation (Kennison, 1995; Ho
et al., 2011), studies have also suggested that BAF complexes can
synergize with PRC for gene regulation (Ho et al., 2011).
The BAF complex is crucial for mammalian nervous system as
mutations in BAF subunits have been implicated in neurological
disorders such as Coffin-Siris syndrome due to mutations in
BRG1 and BRM (Tsurusaki et al., 2012; Ronan et al., 2013),
and SS18L1/CREST in amyotrophic lateral sclerosis (ALS)
(Chesi et al., 2013). During neural development, several BAF
complex subunit switches to form the neuron-specific BAF
(nBAF) complex (Staahl and Crabtree, 2013). The assembly
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of the nBAF complex requires the switching of progenitor
subunits (BAF53a, BAF45a, and SS18) to neuronal subunits
(BAF53b, BAF45b or BAF45c, and SS18L1/CREST) between
the proliferating ventricular zone and the post-mitotic zone
(Olave, 2002; Lessard et al., 2007; Wu et al., 2007; Yoo et al.,
2009; Staahl et al., 2013). These molecular switches also occur
during miRNA-mediated direct conversion of human fibroblasts
into neurons (Staahl et al., 2013), in which the reciprocal
switching of BAF53a to BAF53b is directly orchestrated by
miR-9/9∗ and miR-124 (Yoo et al., 2009; Staahl et al., 2013;
Figure 1). The assembly of the nBAF complex is essential
for proper neuronal function in learning and memory as loss
of function of either BAF53b or SS18L1/CREST dramatically
reduced dendritic outgrowth and morphology (Aizawa et al.,
2004; Wu et al., 2007; Staahl et al., 2013; Vogel-Ciernia
et al., 2013). The function of chromatin remodeling by
BAF complex was also found to be critical for neuronal
reprogramming as loss of BRG1 during miRNA-mediated
FIGURE 1 | MiR-9/9∗-124-mediated neuronal reprogramming of human adult fibroblasts. Ectopic expression of miR-9/9∗-124 in human adult fibroblasts leads to
the switching of several non-neuronal to neuronal components for neural fate acquisition. MiRNAs orchestrate the genetic switching of epigenetic regulators
including the BAF complex subunits (BAF53a, BAF45a, and SS18 to BAF53b, BAF45b/c, and SS18L1/CREST), TOP2A to TOP2B, and DNMT3B to DNMT3A.
These coordinated molecular switches underlie the establishment of a neuronal epigenetic landscape during neuronal reprogramming. Additionally, the switching of
PTB proteins, from PTBP1 to PTBP2, mediated by miR-124 activates neuron-specific alternative splicing program.
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reprogramming abolished the chromatin landscape permissive
to the activation of the neuronal program (Abernathy et al.,
2017).
SWITCHING OF CHROMATIN
MODIFIERS ARE CRUCIAL FOR CELL
FATE CONVERSION
The switching of other homologous epigenetic regulators also
occur during neurogenesis and neuronal reprogramming, though
may not be direct targets of miR-9/9∗-124. These include the
switching of DNA topoisomerase II (TOP2) that functions to
decatenate and catenate chromatin, from non-neuronal TOP2A
to neuronal TOP2B (Watanabe et al., 1994; Tsutsui et al., 2001a;
Tiwari et al., 2012; Thakurela et al., 2013). TOP2A is expressed
in mitotic cells and interacts with BAF complexes to modulate
chromatin accessibility (Tsutsui et al., 2001b; Dykhuizen et al.,
2013; Wijdeven et al., 2015; Miller et al., 2017). On the other
hand, TOP2B is required for neuronal differentiation in vitro
and in vivo (Yang, 2000; Tsutsui et al., 2001b; Tiwari et al.,
2012). Consistent with neuronal differentiation, miR-9/9∗-124
instruct the similar switch of TOP2 homologs during neuronal
reprogramming of human adult fibroblasts by inducing a rapid
reduction of TOP2A in fibroblasts for the selective expression
TOP2B in converted neurons (Abernathy et al., 2017; Figure 1).
Similarly, the reconfiguration of the epigenetic landscape
during neuronal reprogramming also involves changes in DNA
methylation patterns (Abernathy et al., 2017). Regarding the
reprogramming activities of the miRNAs, it has been shown that
ectopic expression of miR-9/9∗-124 in fibroblasts recapitulated
the molecular switching of de novo methyltransferases, DNMT3B
to DNMT3A, similarly, to neural differentiation in vivo (Feng
et al., 2005; Watanabe et al., 2006; Abernathy et al., 2017;
Figure 1). DNMT3A has been implicated in various aspects of
neuronal development, including synaptic plasticity (Feng et al.,
2010; Colquitt et al., 2014), but it remains unclear how DNMT3A
modulates gene expression in the nervous system. Although DNA
methylation is viewed as a repressive mark, methylation marks
deposited by DNMT3A have also been associated with enhanced
gene expression through antagonizing PRC2 activity (Wu et al.,
2010). The dramatic change in DNA methylation profile in
miRNA-induced neurons also involves the induction of a family
of demethylase, ten–eleven translocation (TET) family proteins
(TET1/2/3) (Abernathy et al., 2017), implicated in neuronal
development (Hahn et al., 2013; Zhang et al., 2013). It should
be noted, however, what additional molecules interact with
DNMT3A and TET proteins during neuronal reprogramming
to influence DNA methylation at specific loci remains largely
unknown.
Although the mechanisms underlying the switching of
epigenetic effectors remain to be precisely defined, it is clear
that miR-9/9∗-124 promote neuronal identity during the direct
reprogramming of human fibroblasts through establishing an
epigenetic state permissive for the downstream acquisition of
neuronal fate. The reciprocal temporal and spatial switching
of chromatin modifiers observed both during neurogenesis and
neuronal reprogramming highlight the complex and dynamic




In addition to epigenetic regulators, post-transcriptional
regulation of gene expression appears to be integral for neuronal
reprogramming. The expression of PTB (polypyrimidine tract-
binding) proteins, PTBP1 and PTBP2, are mutually exclusive and
exhibit reciprocal switching during neural fate acquisition (Boutz
et al., 2007). PTB proteins are RNA-binding proteins that bind
to U-rich tracts primarily in introns for the post-transcriptional
regulation of mRNAs, including alternative splicing (Wagner
and Garcia-Blanco, 2001; Keppetipola et al., 2012). PTBP1 is
expressed in non-neuronal cells and neural progenitors whereas
the expression of its neuronal homolog, PTBP2 (nPTB), a
splicing target of PTBP1, is primarily restricted to post-mitotic
neurons in the nervous system (Boutz et al., 2007; Makeyev
et al., 2007). PTBP1 represses PTBP2 expression by introducing
a premature stop through the skipping of PTBP2 exon (Boutz
et al., 2007). During development, the expression of miR-124 at
the onset of neurogenesis mediates the switching of PTB proteins
by targeting the 3′UTR of PTBP1, thereby alleviating PTBP1-
mediated repression of PTBP2 in neurons (Makeyev et al.,
2007). Although PTB proteins exhibit functional redundancy
(Spellman et al., 2007), PTBP2 in neurons are essential for
the proper splicing of various transcripts involved in neuronal
function (Boutz et al., 2007; Licatalosi et al., 2012; Zheng et al.,
2012; Li et al., 2014). Interestingly, ablating PTBP1 function in
several cell types, including mouse embryonic fibroblasts, though
insufficient in human fibroblasts, led to the direct conversion
into neurons (Xue et al., 2013; Xue Y. et al., 2016), suggesting
the significance of PTBP2 for the induction of neuronal fate. In
addition to the activation of PTBP2 upon neural fate acquisition,
PTBP2 level attenuates later in development for neuronal
maturation (Li et al., 2014; Xue Y. et al., 2016). The attenuation
of PTBP2 can be recapitulated with sequential knockdown of
both PTB proteins resulting in the reprogramming of human
fibroblasts into neurons (Xue Y. et al., 2016). The proposed
mechanism is that PTBP2 reduction initiates a regulatory loop
that activates downstream BRN2 for miR-9 expression, which
dampens PTBP2 activity through 3′UTR targeting (Xue Y.
et al., 2016). Altogether, PTBP2 level is dynamically regulated
throughout neuronal differentiation and is essential as PTBP2
knockout results in neuronal death (Li et al., 2014).
THE USE OF miRNA-INDUCED
NEURONAL GROUND STATE FOR
SUBTYPE-SPECIFIC NEURONAL
REPROGRAMMING
As neurological disorders affect distinct neuronal subtypes,
the generation of neuronal subtypes has been of interest not
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only for dissecting the underlying mechanisms behind subtype-
specific neuronal conversion, but also for the implication of the
reprogrammed neurons in disease modeling. MiR-9/9∗-124 have
been shown to induce a “default” neuronal state characterized
by enhanced accessibility of chromatin regions encompassing
neuronal genes (Figure 2). These regions include genes
specifically expressed in distinct neuronal subtypes, yet remain
inactivated, thereby providing the chromatin environment that is
open and permissive for subtype-defining inputs of transcription
factors (Abernathy et al., 2017). Furthermore, unlike iPSC-
based reprogramming methods, direct neuronal conversion
bypasses an embryonic intermediate (Lapasset et al., 2011; Miller
et al., 2013), thereby retaining the age signatures of starting
fibroblasts including the epigenetic clock (Horvath, 2013), age-
associated changes in transcriptome and microRNAs, reactive
oxygen species (ROS) levels, DNA damage and telomere lengths
(Mertens et al., 2015; Huh et al., 2016; Tang et al., 2017). As direct
neuronal conversion can faithfully recapitulate age-associated
phenotypes, directly reprogrammed neurons hold promise in
the modeling of adult-onset neurodegenerative diseases and
necessitates the control of subtype-specificity during neuronal
reprogramming.
The use of synergism between miRNAs and subtype-defining
transcription factors to obtain subtype-specific neurons has
been successful in generating cortical neurons (Yoo et al.,
2011), striatal medium spiny neurons (MSN) (Victor et al.,
2014), and spinal cord motor neurons (Abernathy et al.,
2017; Figure 2). For instance, heterogeneous population of
excitatory and inhibitory neurons belonging to the cortex can
be obtained with the use of miR-9/9∗-124 in combination
with NEUROD2, ASCL1, and MYT1L (DAM) cocktail from
adult fibroblasts (Yoo et al., 2011). However, it remains to
be tested whether layer-enriched transcription factors would
be able to further guide the cortical lineage to neurons with
layer-specific identities. Since previous studies demonstrated
the plasticity of cortical neurons being able to transition
between cortical layer fates (Rouaux and Arlotta, 2010, 2013;
De la Rossa et al., 2013), it raises the potential that a
similar approach may be taken in a cellular reprogramming
context.
An enriched population of striatal MSN, the neuronal subtype
primarily degenerated in Huntington’s disease (HD), can be
derived using miR-9/9∗-124 in conjunction with CTIP2, DLX1/2,
and MYT1L (CDM) factors (Victor et al., 2014). More than
FIGURE 2 | Synergism between microRNAs and transcription factors for subtype-specific neuronal reprogramming of human adult fibroblasts. MiR-9/9∗-124
mediate the erasure of fibroblast fate through remodeling of a fibroblast-specific chromatin landscape and transcriptome profile and promote a neuronal chromatin
landscape and transcriptome. MiRNA alone generates a default neuronal state characterized by the reconfiguration of the chromatin state permissive to the
subtype-defining inputs of transcription factors. With distinct combinations of transcription factors, the miRNA-based conversion have been successfully employed
to generate cortical neurons (Yoo et al., 2011), striatal medium spiny neurons (Victor et al., 2014), and spinal cord motor neurons (Abernathy et al., 2017).
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70% of cells express DARPP32, a marker of MSNs, and when
injected into the stratum of mouse pups, the converted MSNs
incorporate and project to the substantia nigra and globus
pallidus in vivo with electrophysiological properties similar to
neighboring endogenous mouse MSNs (Victor et al., 2014).
Interestingly, applying the MSN-specific neuronal conversion
approach in fibroblast samples from symptomatic patients has
proven to be successful in generating patient-specific MSNs
manifesting hallmark HD pathology, including HTT aggregation,
spontaneous neuronal death, and increased DNA damage
(Victor et al., 2018). Importantly, the manifestation of HD-
associated phenotypes was dependent on the specificity of the
type of neurons generated and the age status in converted
neurons, further highlighting the importance of age and subtype-
specificity in modeling adult-onset diseases (Victor et al.,
2018).
Spinal cord motor neurons are most susceptible to
degeneration in amyotrophic lateral sclerosis (ALS) and spinal
muscular atrophy (SMA) diseases, and devising a conversion
protocol could be instrumental to the study and modeling
of motor neuron (MN) diseases. Using a combination of
NEUROG1, SOX11, ISL1, and LHX3 (NSIL), MNs can be
generated from fibroblasts of ALS patients in which the patient-
derived MNs manifest various ALS pathologies, including
FUS protein mislocalization and neuronal degeneration (Liu
et al., 2016). Alternatively, miRNAs in conjunction with two
transcription factors, ISL1 and LHX3, have been shown to
generate functional mature MNs that display transcriptional
signatures similar to in vivo mouse spinal MNs (Abernathy
et al., 2017). Despite the robustness in generating a highly
enriched population of spinal cord MNs, it remains to
be demonstrated whether the MNs derived through the
miRNA-induced neuronal state can be used to model ALS or
SMA.
The use of transcription factors only, ASCL1, NURR1,
and LMX1A, to directly convert fibroblasts of healthy
and Parkinson’s disease (PD) patients into dopaminergic
cells is possible but with limited efficiency in human cells
(Caiazzo et al., 2011). Interestingly, reprogramming efficiency
improved with the addition of neuronal miRNA, miR-124,
and shRNA against p53, to the transcription factor cocktail
using adult fibroblasts (Jiang et al., 2015). One of the
proposed mechanisms behind this enhancement is due to
the activation of TET proteins, in particular TET1, during
reprogramming, as knockdown of TET1 results in increased
cell death while overexpression enhances the overall number
of TUBB3 and TH positive cells (Jiang et al., 2015). The
induction of TET family members has also been observed
in miR-9/9∗-124-mediated reprogramming (Abernathy et al.,
2017).
The generation of additional neuronal subtypes, including
serotonergic neurons for the study of neuropsychiatric disorders
such as schizophrenia (Vadodaria et al., 2016; Xu et al., 2016)
and sensory neurons for the study of pain sensation (Blanchard
et al., 2015; Wainger et al., 2015) have been demonstrated using
the transcription factor approach. It remains to be tested whether
miR-9/9∗-124 could be combined with similar transcription
factors to enhance overall conversion efficiency in human
cells.
SUMMARY
MiR-9/9∗-124-mediated direct conversion of human adult
fibroblasts into functional neurons reconfigures and establishes
a pan-neuronal epigenetic landscape permissive on which
brain region-enriched transcription factors can act and
generate specific neuronal subtype. MiR-9/9∗-124 are potent
neurogenic molecules as they mediate numerous genetic
switches that occur during neurogenesis, in which many
include epigenetic players and pro-neurogenic effectors that
are important to overcome cell fate barriers and activate
neuronal fate programs. As miRNAs regulate expression
of multiple genes, the pro-neural environment established
by the miRNAs allow for the use of this paradigm for
the study of neural fate acquisition. To better understand
and address the role of brain-enriched miRNAs, examining
miRNA-mRNA network would provide invaluable insights
to the acquisition of neuronal fate. Though much remains
to be uncovered, with the maintenance of age of starting
fibroblasts preserved after cellular conversion, modeling
age-dependent neurodegenerative diseases through direct
reprogramming allows for the faithful recapitulation of
age-associated pathogenesis for mechanistic studies of the
disease.
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